Cargando…

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and carries the worst prognosis, characterized by the lack of progesterone, estrogen, and HER2 gene expression. This study aimed to analyze cancer stemness-related gene signature to determine patients’ risk stratifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gul, Samina, Pang, Jianyu, Yuan, Hongjun, Chen, Yongzhi, yu, Qian, Wang, Hui, Tang, Wenru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662149/ https://www.ncbi.nlm.nih.gov/pubmed/37985782 http://dx.doi.org/10.1038/s41597-023-02709-8

Ejemplares similares

The Value of the Stemness Index in Ovarian Cancer Prognosis
por: Yuan, Hongjun, et al.
Publicado: (2022)

Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer
por: Gao, Yinqi, et al.
Publicado: (2021)

Application of Novel Transcription Factor Machine Learning Model and Targeted Drug Combination Therapy Strategy in Triple Negative Breast Cancer
por: Pang, Jianyu, et al.
Publicado: (2023)

Bioinformatics Analysis and Structure of Gastric Cancer Prognosis Model Based on Lipid Metabolism and Immune Microenvironment
por: Chen, Yongzhi, et al.
Publicado: (2022)

Integrating Single-cell RNA-seq to construct a Neutrophil prognostic model for predicting immune responses in non-small cell lung cancer
por: Pang, Jianyu, et al.
Publicado: (2022)

Identification of Target Genes Related to Sulfasalazine in Triple-Negative Breast Cancer Through Network Pharmacology
por: Yu, Haochen, et al.
Publicado: (2020)

Construction and Verification of a Hypoxia-Stemness-Based Gene Signature for Risk Stratification in Esophageal Cancer
por: Tang, Kang, et al.
Publicado: (2021)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

A network meta-analysis on the efficacy of targeted agents in combination with chemotherapy for treatment of advanced/metastatic triple-negative breast cancer
por: Ge, Long, et al.
Publicado: (2017)

Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis
por: Li, Zhen-Yu, et al.
Publicado: (2020)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

Single-Cell Proteomic Profiling Identifies Nanoparticle Enhanced Therapy for Triple Negative Breast Cancer Stem Cells
por: Wang, Wenzheng, et al.
Publicado: (2021)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021)

Identification of a novel glycolysis-related prognosis risk signature in triple-negative breast cancer
por: Ruan, Yuxia, et al.
Publicado: (2023)

Single-cell and bulk RNA-sequencing analysis to predict the role and clinical value of CD36 in lung squamous cell carcinoma
por: Wang, Hui, et al.
Publicado: (2023)

Mutational signature learning with supervised negative binomial non-negative matrix factorization
por: Lyu, Xinrui, et al.
Publicado: (2020)

Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer
por: Zhao, Hongying, et al.
Publicado: (2023)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

Simvastatin induced ferroptosis for triple-negative breast cancer therapy
por: Yao, Xianxian, et al.
Publicado: (2021)

Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Lu, Fei, et al.
Publicado: (2021)

Nucleolar and Coiled-Body Phosphoprotein 1 Is Associated With Stemness and Represents a Potential Therapeutic Target in Triple-Negative Breast Cancer
por: Chen, Sisi, et al.
Publicado: (2022)

Homologous recombination deficiency predicts the response to platinum-based neoadjuvant chemotherapy in early-stage triple-negative breast cancer patients: a systematic review and meta-analysis
por: Zhang, Liulu, et al.
Publicado: (2022)

A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
por: Zheng, Tianzhi, et al.
Publicado: (2019)

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
por: Jézéquel, Pascal, et al.
Publicado: (2019)

Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
por: Gao, Bowen, et al.
Publicado: (2021)

Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
por: Karn, Thomas, et al.
Publicado: (2011)

Identification of a prognosis-associated signature associated with energy metabolism in triple-negative breast cancer
por: Li, Chao, et al.
Publicado: (2020)

Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer
por: Chalakur-Ramireddy, Naveen K.R., et al.
Publicado: (2018)

Distinct microbiological signatures associated with triple negative breast cancer
por: Banerjee, Sagarika, et al.
Publicado: (2015)

An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2023)

Identification of a NACC1-Regulated Gene Signature Implicated in the Features of Triple-Negative Breast Cancer
por: Ngule, Chrispus M., et al.
Publicado: (2023)

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
por: Liu, Jeff C., et al.
Publicado: (2018)

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022)

Meta-analysis of single-cell and single-nucleus transcriptomics reveals kidney cell type consensus signatures
por: Quatredeniers, Marceau, et al.
Publicado: (2023)

Mutational signatures reveal mutual exclusivity of homologous recombination and mismatch repair deficiencies in colorectal and stomach tumors
por: Farmanbar, Amir, et al.
Publicado: (2023)

COVID-19 response: mitigating negative impacts on other areas of health
por: Hrynick, Tabitha A, et al.
Publicado: (2021)

Construction and Identification of New Molecular Markers of Triple-Negative Breast Cancer Stem Cells
por: Liu, Tingting, et al.
Publicado: (2021)

Characterization of immune microenvironment in patients with HPV-positive and negative head and neck cancer
por: Wang, Zhongqiu, et al.
Publicado: (2023)

A novel signature based on immune‐related gene pairs and clinical features to predict prognosis and treatment effect in “driver gene negative” lung adenocarcinoma
por: Cai, He‐yuan, et al.
Publicado: (2022)

Eliminating HIV transmission through breast milk from women taking antiretroviral drugs
por: Goga, Ameena E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s31l0h36cqtg3hhucsmpb99442